634
G. Martinez et al. / Tetrahedron Letters 54 (2013) 630–634
NaHCO3 (2 ꢀ 15 mL), dried (MgSO4), filtered and the solvent was removed in
vacuo. The crude product was purified by radial chromatography to give 3
(0.328 g, 63%) as a viscous oil: IR (neat) 3168, 1651, 1596 cmꢁ1 1H NMR
(200 MHz, CDCl3) d 7.40–7.33 (m, 5H), 6.89 (dd, J = 1.4, 6.9 Hz, 1H), 6.67 (dd,
J = 1.6, 7.5 Hz, 1H), 6.58 (dd, J = 8.7, 16.8 Hz, 1H), 6.19 (d, J = 16.4 Hz, 1H), 6.10
(t, J = 7.1 Hz, 1H), 6.01 (t, J = 6.4 Hz, 1H), 5.85 (d, J = 10.2 Hz, 1H), 5.12 (s, 2H),
4.13 (t, J = 6.0 Hz, 2H), 2.96 (q, J = 6.1 Hz, 2H), 1.96 (quin, J = 5.9 Hz, 2H); 13C
NMR (200 MHz, CDCl3) d 158.4, 148.5, 136.2, 135.9, 128.8, 128.4, 127.9, 127.2,
125.6, 115.7, 105.5, 70.6, 46.1, 39.2, 29.8; Anal. Calcd for C17H20N2O4S: C,
58.60; H, 5.79; N, 8.04. Found: C, 58.24; H, 5.47; N, 7.84.
References and notes
;
1. (a) Young, J. A.; Karmakar, S.; Jacobs, H. K.; Gopalan, A. S. Tetrahedron 2012, 68,
10030; (b) Liu, Y.; Jacobs, H. K.; Gopalan, A. S. J. Org. Chem. 2009, 74, 782; (c)
Chittamuru, S.; Lambert, T. N.; Martinez, G.; Jacobs, H. K.; Gopalan, A. S.
Tetrahedron Lett. 2007, 48, 567; (d) Thompson, K. H.; Barta, C. A.; Orvig, C. Chem.
Soc. Rev. 2006, 35, 545; (e) Xu, J.; Whisenhunt, D. W., Jr.; Veeck, A. C.; Uhlir, L.
C.; Raymond, K. N. Inorg. Chem. 2003, 42, 2665; (f) Santos, M. A. Coord. Chem.
Rev. 2002, 228, 187; (g) Lambert, T. N.; Dasaradhi, L.; Huber, V. J.; Gopalan, A. S.
J. Org. Chem. 1999, 64, 6097.
2. Santos, M. A.; Marques, S. M.; Chaves, S. Coord. Chem. Rev. 2012, 256, 240.
3. (a) Crisponi, G.; Remelli, M. Coord. Chem. Rev. 2008, 252, 1225; (b) Hider, R. C.;
Liu, Z. D. Curr. Med. Chem. 2003, 10, 1051; (c) Liu, Z. D.; Hider, R. C. Med. Res. Rev.
2002, 22, 26–64; (d) Yokel, R. A.; Fredenburg, A. M.; Durbin, P. W.; Xu, J. D.;
Rayens, M. K.; Raymond, K. N. J. Pharm. Sci. 2000, 89, 545.
21. Reddick, J. J.; Cheng, J.; Roush, W. R. Org. Lett. 2003, 5, 1967.
22. Makara, G. M.; Ma, Y. Tetrahedron Lett. 2001, 42, 4123.
23. (a) Joshi, J. H.; Saiyed, A. S.; Bedekar, A. V. Synth. Commun. 2010, 40, 2857; (b)
Matveeva, E. V.; Petrovskii, P. V.; Odinets, I. L. Tetrahedron Lett. 2008, 49, 6129;
(c) Ranu, B. C.; Banerjee, S. Tetrahedron Lett. 2007, 48, 141; (d) Azizi, N.;
Aryanasab, F.; Torkiyan, L.; Ziyaei, A.; Saidi, M. R. J. Org. Chem. 2006, 71, 3634;
(e) Chaudhuri, M. K.; Hussain, S.; Kantam, M. L.; Neelima, B. Tetrahedron Lett.
2005, 46, 8329; (f) Srilakshmi Krishnaveni, N.; Surendra, K.; Rama Rao, D. Chem.
Commun. 2005, 669.
24. Naidu, B. N.; Sorenson, M. E.; Connolly, T. P.; Ueda, Y. J. Org. Chem. 2003, 68,
10098.
25. De Castries, A.; Escande, A.; Fensterbank, H.; Magnier, E.; Marrot, J.; Larpent, C.
Tetrahedron 2007, 63, 10330.
4. (a) Weinberg, E. D. Adv. Appl. Microbiol. 2003, 52, 187; (b) Buss, J. L.; Torti, F. M.;
Torti, S. V. Curr. Med. Chem. 2003, 10, 1021.
5. Datta, A.; Raymond, K. N. Acc. Chem. Res. 2009, 42, 938.
6. (a) Werner, E. J.; Datta, A.; Jocher, C. J.; Raymond, K. N. Angew. Chem. 2008, 47,
8568; (b) Pierre, V. C.; Botta, M.; Aime, S.; Raymond, K. N. J. Am. Chem. Soc.
2006, 128, 5344; (c) Raymond, K. N.; Pierre, V. C. Bioconjugate Chem. 2005, 16, 3;
(d) Thompson, M. K.; Misselwitz, B.; Tso, L. S.; Doble, D. M. J.; Schmitt-Willich,
H.; Raymond, K. N. J. Med. Chem 2005, 48, 3874.
7. (a) Klemm, P. J.; Floyd, W. C., III; Andolina, C. M.; Fréchet, J. M. J.; Raymond, K. N.
Eur. J. Inorg. Chem. 2012, 2108; (b) Floyd, W. C., III; Klemm, P. J.; Smiles, D. E.;
Kohlgruber, A. C.; Pierre, V. C.; Mynar, J. L.; Fréchet, J. M. J.; Raymond, K. N. J. Am.
Chem. Soc. 2011, 133, 2390; (c) Zhou, T.; Neubert, H.; Liu, D. Y.; Liu, Z. D.; Ma, Y.
M.; Kong, X. L.; Luo, W.; Mark, S.; Hider, R. C. J. Med. Chem. 2006, 49, 4171.
8. Datta, A.; Hooker, J. M.; Botta, M.; Francis, M. B.; Aime, S.; Raymond, K. N. J. Am.
Chem. Soc. 2008, 130, 2546.
9. (a) Berry, D. J.; Ma, Y.; Ballinger, J. R.; Tavaré, R.; Koers, A.; Sunassee, K.; Zhou,
T.; Nawaz, S.; Mullen, G. E. D.; Hider, R. C.; Blower, P. J. Chem. Commun. 2011,
47, 7068; (b) Chaves, S.; Mendonca, A. C.; Marques, S. M.; Prata, M. I.; Santos, A.
C.; Martins, A. F.; Geraldes, C. F. G. C.; Santos, M. A. J. Inorg. Biochem. 2011, 105,
31.
26. Jung, Y.; Marcus, R. A. J. Am. Chem. Soc. 2007, 129, 5492.
27. Loh, T.-P.; Wei, L.-L. Synlett 1998, 975.
28. Harrington, J. M.; Chittamuru, S.; Dhungana, S.; Jacobs, H. K.; Gopalan, A. S.;
Crumbliss, A. L. Inorg. Chem. 2010, 49, 8208.
29. Rulev, A. Y. Russ. Chem. Rev. 2011, 80, 197.
30. Synthesis of disulfonamide 6. To
a solution of HOPO vinyl sulfonamide 3
(0.050 g, 0.143 mmol) in 2:3 THF/H2O (5 mL) was added piperazine (0.006 g,
0.068 mmol) and the solution stirred at rt for 24 h. The solvent was removed in
vacuo and the resulting residue was extracted into dichloromethane
(3 ꢀ 10 mL). The combined organic extracts were dried (MgSO4), filtered, and
the solvent removed in vacuo. The crude product was purified by radial
chromatography to give 6 (0.051 g, 94%) as a white solid: mp 46–48 °C; IR (KBr)
3435, 1650, 1598 cmꢁ1 1H NMR (400 MHz, CDCl3) d 1.97 (quin, J = 6.1 Hz, 4H),
;
10. (a) Wilden, J. D. J. Chem. Res. 2010, 541; (b) Block, J. H.; Brackett, C. C.; Singh, H.;
Block, P. D. Pharmacotherapy 2004, 24, 856.
11. (a) Supuran, C. T.; Vullo, D.; Franchi, M.; Gallori, E.; Antel, J.; Scozzafava, A. J.
Med. Chem. 2004, 47, 1272; (b) Macías, B.; García, I.; Villa, M. A.; Borrás, J.;
Castiñerias, A.; Sanz, F. Z. Anorg. Allg. Chem. 2003, 629, 255.
2.46 (br s, 8H), 2.81 (t, J = 7.0 Hz, 4H), 3.13–3.04 (m, 8H), 4.09 (t, J = 6.2 Hz, 4H),
5.09 (s, 4H), 6.10 (t, J = 7.1 Hz, 4H), 6.68 (dd, J = 1.6, 7.4 Hz, 2H), 6.91 (dd, J = 1.7,
6.8 Hz, 2H), 7.43–7.30 (m, 10H); 13C NMR (50 MHz, CDCl3) d 30.5, 39.5, 49.0,
46.2, 52.1, 52.7, 70.7, 105.4, 115.7, 127.3, 128.0, 128.5, 128.8, 136.0, 148.7,
158.5. Anal. Calcd for C38H50N6O8S2ꢂH2O: C, 56.98; H, 6.54; N, 10.49. Found: C,
56.95; H, 6.12; N, 10.09.
12. Supuran, C. T.; Innocenti, A.; Casini, A.; Alcar, M. C.; Papini, A. M.; Scozzafava, A.
J. Med. Chem. 2004, 47, 5224.
31. Synthesis of diHOPO 7. A solution of 1:1 48% HBr/AcOH (3 mL) was added to
protected HOPO sulfonamide 6 (0.051 g, 0.065 mmol) and the solution stirred
at rt for 18 h. The solvent was removed in vacuo. The residue was washed with
CHCl3 (2 ꢀ 5 mL), and EtOAc (2 ꢀ 5 mL). The washed product was dissolved in
nanopure water and lyopholized to give the diHOPO 7 (0.046 g, 92%) as a white
13. Tanakit, A.; Rouffet, M.; Martin, D. P.; Cohen, S. M. Dalton Trans. 2012, 41, 6507.
14. (a) García Ruano, J. L.; Parra, A.; Marzo, L.; Yuste, F.; Mastranzo, V. M.
Tetrahedron 2011, 67, 2905; (b) Caddick, S.; Wilden, J. D.; Bush, H. D.; Wadman,
S. N.; Judd, D. B. Org. Lett. 2002, 4, 2549; (c) Caddick, S.; Wilden, J. D.; Judd, D. B.
J. Am. Chem. Soc. 2004, 126, 1024; (d) Berthelette, C.; Chan, W. Y. Tetrahedron
Lett. 2002, 43, 4537.
15. (a) Bahrami, K.; Khodaei, M. M.; Abbasi, J. Tetrahedron 2012, 68, 5095; (b)
Massah, A. R.; Sayadi, S.; Ebrahimi, S. RSC Adv. 2012, 2, 6606; (c) Gareau, Y.;
Pellicelli, J.; Laliberté, S.; Gauvreau, D. Tetrahedron Lett. 2003, 44, 7821.
16. Chen, C.; Chen, Q. Tetrahedron Lett. 2004, 45, 3957.
17. (a) Zang, Q.; Javed, S.; Porubsky, P.; Ullah, F.; Neuenswander, B.; Lushington, G.
H.; Basha, F. Z.; Organ, M. G.; Hanson, P. R. ACS Comb. Sci. 2012, 14, 211; (b)
Ullah, F.; Zang, Q.; Javed, S.; Porubsky, P.; Neuenswander, B.; Lushington, G. H.;
Hanson, P. R.; Organ, M. G. Synthesis 2012, 44, 2547; (c) Fenster, E.; Long, T. R.;
Zang, Q.; Hill, D.; Neuenswander, B.; Lushington, G. H.; Zhou, A.; Santini, C.;
Hanson, P. R. ACS Comb. Sci. 2011, 13, 244; (d) Rolfe, A.; Lushington, G. H.;
Hanson, P. R. Org. Biomol. Chem. 2010, 8, 2198; (e) Morris, J.; Wishka, D. G. J.
Org. Chem. 1991, 56, 3549.
solid: mp 92–94 °C (dec); IR (KBr) 3368, 3119, 2532, 1674, 1583 cmꢁ1 1H NMR
;
(300 MHz, D2O) d 2.02 (quin, J = 6.7 Hz, 4H), 3.16 (t, J = 6.7 Hz, 4H), 3.67–3.47
(m, 16H), 4.10 (t, J = 6.9 Hz, 4H), 6.39 (t, J = 7.2 Hz, 2H), 7.00 (dd, J = 1.8, 7.3 Hz,
2H), 7.19 (dd, J = 1.6, 6.8 Hz, 2H); 13C NMR (100 MHz, D2O) d 29.7, 40.7, 46.9,
48.2, 50.2, 51.4, 109.3, 119.4, 130.1, 146.1, 159.3. Anal. Calcd for
C
24H38N6O8S2ꢂ3HBrꢂ3H2O: C, 32.05; H, 5.27; N, 9.34. Found: C, 31.90; H, 5.14;
N, 9.32.
32. Bis-HOPO 16. Mp 105–110 °C; IR (KBr) 3251, 1645, 1613, 1557 cmꢁ1 1H NMR
;
(200 MHz, CD3OD) d 1.60–1.73 (quin, 4H), 2.49 (t, J = 5.5 Hz, 4H), 2.81 (t,
J = 6.24 Hz, 4H), 3.27 (t, J = 6.22 Hz, 4H), 3.52 (br s, 8H), 3.90 (t, J = 6.96 Hz, 4H),
6.27 (t, J = 6.96 Hz, 2H), 6.79 (d, J = 7.32 Hz, 2H), 7.14 (d, J = 6.24 Hz, 2H); 13C
NMR (50 MHz, D2O) d 27.8, 29.3, 36.22, 47.1, 48.7, 52.8, 108.9, 118.8, 129.0,
145.3, 158.2, 170.6. Anal. Calcd for C26H38N6O6ꢂ3HBrꢂ2.5H2O: C, 38.16; H, 5.66;
N, 10.27. Found: C, 38.02; H, 5.30; N, 9.97.
18. Li, M.; Wu, R. S.; Tsai, J. S. C.; Salamone, S. J. Bioorg. Med. Chem. Lett. 2003, 13,
383.
33. Tris-HOPO 18. Mp 60–65 °C; IR (KBr) 3391, 1651, 1550 cmꢁ1
;
1H NMR
1.81–1.91 (m, 6H), 2.67 (t, J = 6.45 Hz, 6H), 3.13 (t,
(300 MHz, D2O)
d
19. Arumugam, J.; Brown, H. A.; Jacobs, H. K.; Gopalan, A. S. Synthesis 2011, 57.
20. Synthesis of HOPO vinylsulfonamide 3: 2-Chloroethanesulfonyl chloride (0.242 g,
1.49 mmol) was added to a solution of triethylamine (0.46 mL, 4.46 mmol) and
HOPO amine 2 (0.461 g, 1.78 mmol) in dichloromethane (6 mL) at rt and the
solution stirred for 5 h. The reaction mixture was diluted with
dichloromethane (20 mL) and washed with 1 M HCl (10 mL), saturated
J = 6.75 Hz, 6H), 3.39–3.44 (m, 18H), 3.94 (t, J = 7.05 Hz, 6H), 6.29 (t,
J = 7.32 Hz, 3H), 6.91 (dd, J = 1.77, 7.62 Hz, 3H), 7.09 (dd, J = 1.77, 7.05 Hz,
3H); 13C NMR (50 MHz, D2O) d 27.8, 29.6, 36.5, 47.6, 49.3, 53.2, 108.4, 118.3,
129.0, 145.3, 158.1, 172.7. Anal. Calcd for C39H57N9Oꢂ5HBr: C, 39.02; H, 5.21; N,
10.50. Found: C, 39.18; H, 5.44; N, 10.32.